Article
Development and validation of a next-generation sequencing assay with open-access analysis software for detecting resistance-associated mutations in CMV.
Journal of clinical microbiology - 19 Dec 2023
Mallory Melanie A, Hymas Weston C, Simmon Keith E, Pyne Michael T, Stevenson Jeffery B, Barker Adam P, Hillyard David R, Hanson Kimberly E
Abstract excerpt
Cytomegalovirus (CMV) resistance testing by targeted next-generation sequencing (NGS) allows for the simultaneous analysis of multiple genes. We developed and validated an amplicon-based Ion Torrent NGS assay to detect CMV resistance mutations in UL27, UL54, UL56, and UL97 and compared the results to standard Sanger sequencing. NGS primers were designed to generate 83 overlapping amplicons of four CMV genes (~10...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
